The Latest Cardiac and Vascular News
KALAMAZOO, Michigan, USA, May 7, 2018 /PRNewswire/ — Following the expanded indication in the United States by the Food and Drug Administration (FDA) in February, Stryker’s Trevo Retriever has received CE marking as a front-line treatment for patients experiencing acute ischemic stroke up to 24 hours from symptom onset, increasing the treatment window by 18 […]
SAN DIEGO, May 09, 2018 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) will hold its 2018 Annual General Meeting of Stockholders (the “AGM”) on Wednesday, May 16, 2018 at 4:00 p.m. US PDT (which is Thursday, 17 May 2018 at 9:00 a.m. AEST). The meeting will […]
SOUTH SAN FRANCISCO, Calif., May 10, 2018 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq:MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases, today announced the start of the PIONEER open-label extension (OLE) study of its investigational drug, mavacamten. MyoKardia recently completed the Phase […]
VANCOUVER, May 10, 2018 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, announced today that it has received written notification (the “Nasdaq Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it has […]
SAN CARLOS, Calif.–(BUSINESS WIRE)–BioCardia®, Inc., (OTC: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced that the Centers for Medicare and Medicaid Services (CMS) has approved national reimbursement coverage for the CardiAMP Chronic Myocardial Ischemia Trial. “We are thankful for the CMS decision to […]
ORANGEBURG, New York, May 10, 2018 /PRNewswire/ —Impulse Dynamics(USA), Inc. announced results from its FIX-HF-5C randomized, Controlled Trial of Cardiac Contractility Modulation in Heart Failure. The study results were presented by Prof. William Abraham, MD, Professor of Internal Medicine and Director, Division of Cardiovascular Medicine, The Ohio State University Wexner […]
CAMBRIDGE, England–(BUSINESS WIRE)–Researchers from PlaqueTec Ltd. presented data suggesting that localised coronary inflammation may be independent of systemic elevation of inflammatory biomarkers such as high-sensitivity C reactive protein (hsCRP). The data, presented at the 86th European Atherosclerosis Society (EAS) Congress in Lisbon, Portugal, are based on analysis of blood samples obtained […]
PARIS–(BUSINESS WIRE)–HighLife SAS, a medtech company focused on the development of a unique trans-catheter mitral valve replacement (TMVR) system to treat patients suffering from mitral regurgitation, announced today the appointment of Dr. Martin T. Rothman as non-executive independent member of its Board of Directors. Dr. Rothman retired recently from his position as Vice President of […]
SANTA CRUZ, Calif.–(BUSINESS WIRE)–Murj, Inc., a digital healthcare company dedicated to helping clinicians streamline and improve care for patients with implantable cardiac devices, today announced that the company has closed an $8.5 million Series B financing led by Longitude Capital, with participation from True Ventures and other existing investors. Murj […]
MINNEAPOLIS, May 9, 2018 /PRNewswire/ — Preventice Solutions announced today the launch of the BodyGuardian® Mini, the smallest, reusable long-term Holter technology available for cardiac monitoring. The new, compactly designed technology includes an ultra-small, lightweight cardiac monitor that enables up to 14-days of ECG measurements that are transmitted to a physician in an […]
